SÜLEYMAN AYDIN

Dr. SÜLEYMAN AYDIN

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 January 2019 in Vascular Health and Risk Management
Verified
Journal Article
Open access
PDF file
SASÜLEYMAN AYDIN
SÜLEYMAN AYDIN
KUKader Ugur
Kader Ugur
SASuna Aydin
Suna Aydin
ISİbRahim Sahin
İbRahim Sahin
MYMeltem Yardim
Meltem Yardim
Purpose: Acute myocardial infarction (AMI) is the most common cause of death in the world. Comprehensive risk assessment of patients presenting with chest pain and eliminating undesirable results should decrease morbidity and mortality rates, increase the quality of life of patients, and decrease health expenditure in many countries. In this study, the advantages and disadvantages of the enzymatic and nonenzymatic biomarkers used in the diagnosis of patients with AMI are given in historical sequence, and some candidate biomarkers – hFABP, GPBB, S100, PAPP-A, RP, TNF, IL6, IL18, CD40 ligand, MPO, MMP9, cell-adhesion molecules, oxidized LDL, glutathione, homocysteine, fibrinogen, and D-dimer procalcitonin – with a possible role in the diagnosis of AMI are discussed. Methods: The present study was carried out using meta-analyses, reviews of clinical trials, evidence-based medicine, and guidelines indexed in PubMed and Web of Science. Results: These numerous AMI biomarkers guide clinical applications (diagnostic methods, risk stratification, and treatment). Today, however, TnI remains the gold standard for the diagnosis of AMI. Details in the text will be given of many biomarkers for the diagnosis of AMI. Conclusion: We evaluated the advantages and disadvantages of routine enzymatic and nonenzymatic biomarkers and the literature evidence of other candidate biomarkers in the diagnosis of AMI, and discuss challenges and constraints that limit translational use from bench to bedside.

1 June 2014 in Peptides
Verified
Journal Article
Closed access
SASÜLEYMAN AYDIN
SÜLEYMAN AYDIN

8 February 2025 in Journal of International Medical Research
Verified
Journal Article
Open access
SASÜLEYMAN AYDIN
SÜLEYMAN AYDIN
EEElif Emre
Elif Emre
KUKader Ugur
Kader Ugur
MAMustafa Ata Aydin
Mustafa Ata Aydin
ISİbRahim Sahin
İbRahim Sahin
TATaner Akbulut
Taner Akbulut
The enzyme-linked immunosorbent assay (ELISA) detects antigen-antibody interactions by using enzyme-labelled conjugates and enzyme substrates that generate colour changes. This review aims to provide an overview of ELISA, its various types, and its applications in detecting metabolites in biological fluids. The article discusses the history of the assay, its underlying principles and procedures, common ELISA protocols, and the most accurate and reliable techniques for measuring peptide molecules in biological fluids. Additionally, we emphasize best laboratory practices to achieve consistent, high-quality results and outline the essential materials for setting up an ELISA laboratory, drawing from our over 30 years of experience in the field.

1 November 2014 in Peptides
Verified
Journal Article
Closed access
SASÜLEYMAN AYDIN
SÜLEYMAN AYDIN
TKTuncay Kuloglu
Tuncay Kuloglu
SASuna Aydin
Suna Aydin
MKMehmet Kalayci
Mehmet Kalayci
MYMusa Yilmaz
Musa Yilmaz
IOİbRahim Hanifi Ozercan
İbRahim Hanifi Ozercan

1 February 2014 in Peptides
Verified
Journal Article
Closed access
SASuna Aydin
Suna Aydin
TKTuncay Kuloglu
Tuncay Kuloglu
SASÜLEYMAN AYDIN
SÜLEYMAN AYDIN
MEMehmet Nesimi Eren
Mehmet Nesimi Eren
ACAhmet Celik
Ahmet Celik
ODOzlem Dabak
Ozlem Dabak